How big is the Cancer Immunotherapy Market?

The Cancer Immunotherapy Market size is expected to reach USD 137.71 billion in 2024 and grow at a CAGR of 10.45% to reach USD 226.34 billion by 2029. Read More

What is the current Cancer Immunotherapy Market size?

In 2024, the Cancer Immunotherapy Market size is expected to reach USD 137.71 billion. Read More

Who are the key players in Cancer Immunotherapy Market?

Amgen Inc., Astellas Pharma, Inc., AstraZeneca PLC, Merck and Co Inc. and OSE Immunotherapeutics are the major companies operating in the Cancer Immunotherapy Market. Read More

Which is the fastest growing region in Cancer Immunotherapy Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Cancer Immunotherapy Market?

In 2024, the North America accounts for the largest market share in Cancer Immunotherapy Market. Read More

What years does this Cancer Immunotherapy Market cover, and what was the market size in 2023?

In 2023, the Cancer Immunotherapy Market size was estimated at USD 123.32 billion. The report covers the Cancer Immunotherapy Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Cancer Immunotherapy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Cancer Immunotherapy Companies

This report lists the top Cancer Immunotherapy companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Cancer Immunotherapy industry.